General contact

Main switchboard

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 a.m. - 5:00 p.m. GMT+1

US switchboard

+1 862 778 21 00
Monday - Friday,
8:30 a.m. - 5:00 p.m. EST


Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999


Investor Relations

Monday - Friday,
8:30 a.m. - 5:30 p.m. GMT+1
(Central European Time)

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Minimizing emissions

Emissions into air

We have worked to eliminate ozone depleting substances (ODS) used in fire extinguishers and refrigerant materials from our affiliates’ operations, and include the inventory and emission of ODS in our reporting, per Global Reporting Initiative standards.

As additional relevant emissions into air, we report halogenated and non-halogenated volatile organic compounds (VOCs) and the inorganic pollutants sulphur dioxide/nitrogen oxide (SO2/NOx). VOCs primarily result from the use of chlorinated and non-halogenated solvents in chemical synthesis operations and cleaning processes. Whenever possible, we take mitigation measures to minimize losses to the atmosphere. Inorganic pollutants, including SOx, NOx and particulates, arise primarily from the combustion of fuels and waste incineration.

Emissions into water

Novartis reports total effluent load for chemical oxygen demand, nitrogen, phosphate and total suspended solids, i.e. amounts actually reaching the aquatic environment. They are determined from concentrations of effluent parameters multiplied by flow volumes of wastewater discharged from our facilities after treatment.

When discharged wastewater is treated off-site, in public wastewater treatment plants for example, the specific removal efficiency of such treatment is considered for the amounts reported.